Shopping Cart
Remove All
Your shopping cart is currently empty
Ziltivekimab (MEDI 5117) is a CHO-expressed humanized monoclonal antibody targeting IL-6/IFNb2 for use in immune system diseases.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $310 | - | In Stock | |
| 5 mg | $536 | - | In Stock | |
| 10 mg | $805 | - | In Stock | |
| 25 mg | $1,665 | - | In Stock |
| Description | Ziltivekimab (MEDI 5117) is a CHO-expressed humanized monoclonal antibody targeting IL-6/IFNb2 for use in immune system diseases. |
| Synonyms | WBP-216, WBP216, MEDI5117, MEDI 5117, EX-6018, EX6018, COR-001, COR001 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | IL-6/IFNb2 |
| Molecular Weight | 145.39 kDa |
| Cas No. | 2226654-05-1 |
| Relative Density. | no data available |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.